Quest Diagnostics in stock split:
This article was originally published in Clinica
Quest Diagnostics, the largest diagnostics provider in the US, is splitting its stock on a two-for-one basis. The dividend shares for holders of record as of May 16 will bring the number of shares outstanding to 97 million. Quest has also gained shareholder approval to alter its charter to increase the total number of shares from 100 million to 300 million.